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Parkinson’s disease is associated with the deposition and accumu-
lation of -synuclein fibrils in the brain. A30P and A53T mutations
have been linked to the early-onset familial disease state. Time-
resolved tryptophan fluorescence energy-transfer measurements
have been used to probe the structures of pseudo-wild-type and
mutant (A30P) -synucleins at physiological pH (7.4), in acidic pH
(4.4) solutions, and in the presence of SDS micelles, a membrane
mimic. Fluorescent donor–energy acceptor (DA) distance distribu-
tions for six different tryptophan3-nitro-tyrosine pairs reveal the
presence of compact, intermediate, and extended conformations
of the protein. CD spectra indicate that the protein develops
substantial helical structure in the presence of SDS micelles. DA
distributions show that micelles induce compaction in the N-
terminal region and expansion of the acidic C terminus. In acidic
solutions, there is an increased population of collapsed structures
in the C-terminal region. Energy-transfer measurements demon-
strate that the average DA distances for the W4–Y19 and Y19–W39
pairs are longer in one of the two disease-related mutants (A30P).
tryptophan  3-nitrotyrosine
Parkinson’s disease (PD) is the most common age-relatedneurodegenerative movement disorder (1). The primary
symptoms of PD are caused by the loss of dopaminergic neurons
in the substantia nigra region of the brainstem (2). A diagnostic
hallmark of PD is the presence in the cerebral cortex of
intracellular inclusions (Lewy bodies and neurites) (3, 4), but the
role of these proteinacious materials in the pathogenic process
has not been established. -Synuclein (-syn), an abundant
140-residue neuronal protein of unknown function (Fig. 1) (5),
is the primary component of the fibrillar inclusions. Autosomal
dominant early-onset PD has been linked to two point mutations
(A53T and A30P) in the gene encoding -syn (6, 7). Introduction
of human wild-type, A30P-mutant, or A53T-mutant -syn into
transgenic animal models produces age-dependent motor dys-
function, neuronal deposits of fibrillar protein, and loss of
dopaminergic neurons, consistent with suggestions that PD may
arise from these protein aggregates (8, 9). In vitro fibrillogenesis
experiments also have shown that the two mutants aggregate
faster than the wild-type protein (10, 11), consistent with the
proposal that the disease is caused by fibril formation. Fibrillar
-syn, however, may be a symptom rather than a cause of the
disease. Recent reports suggest that the formation of soluble
oligomeric intermediates is accelerated in the A30Pmutant (12).
Although there are contradictory results, the A30P mutant has
been reported to bind more weakly to lipid vesicles than does the
wild-type protein (13–16). These observations point to a role for
prefibrillar species in PD (12, 17) and, further, suggest that -syn
interaction with synaptic-vesicle membranes may be involved in
the pathogenic mechanism (18, 19). Indeed, it has been proposed
that fibrillar aggregates are a byproduct of neuronal death and
that the formation of Lewy bodies could be a protective mech-
anism to sequester neurotoxic species (20–23).
-syn is localized in the cytosol and presynaptic terminals of
neurons, with some fractions associated with synaptic-vesicle
membranes (24–27). Although its function has not been fully
determined, suggestions include a role in neuronal plasticity and
synaptogenesis (24, 28) and as a protein-folding chaperone (29).
The amino acid sequence includes seven imperfect repeats
(consensus XKTKEGVXXXX) in the N-terminal portion that
are similar to an 11-residue repeating motif in exchangeable
apolipoproteins (Fig. 1) (24). This similarity suggests that the
protein may be capable of reversibly binding to the surfaces of
lipid membranes (14, 15, 18, 30). A distinguishing characteristic
of the amino acid sequence is the highly acidic C-terminal region.
In vitro, -syn has been characterized as a monomeric, intrinsi-
cally unstructured (natively unfolded) protein (31). Traditional
physical techniques such as x-ray diffraction and NMR spectros-
copy provide little insight into the properties of dynamic and
heterogeneous polypeptide ensembles. Small-angle x-ray scat-
tering studies indicate that the protein has a radius of gyration
(Rg) of 40 Å, larger than expected for a folded globular (15 Å)
polypeptide (32). However, in the presence of acidic phospho-
lipid vesicles, the protein undergoes a conformational change,
forming some -helical structure (estimated to be as high as 71%
helical content) observable by CD (30) and NMR spectroscopies
(33–35), as well as by EPR studies (36, 37). Interestingly, in
contrast to the monomeric protein, larger oligomeric interme-
diates form -sheet structures that cause membrane leakage in
vitro (19, 38), providing further support for the hypothesis that
prefibrillar structures may be cytotoxic. It also has been shown
that, at higher protein concentrations (100 M), -syn exhibits
-structure before fibril formation (10). Large environmentally
induced conformational changes of this type are particularly
interesting. Toxic conformers of otherwise benign proteins have
been invoked as pathogens in a number of neurodegenerative
diseases (39, 40).
We have used time-resolved f luorescence energy-transfer
(FET) measurements to probe the structure and dynamics of
pseudo-wild-type and disease-related (A30P) -syn. FET rates
depend on the inverse sixth power of the f luorescent donor–
energy acceptor (DA) distance (41); analysis of f luorescence
decay kinetics can provide probability distributions of DA
distances (42–45). A f luorescent amino acid [tryptophan
(Trp)] and a chemically modified tyrosine (Tyr) {3-
nitrotyrosine [Y(NO2)]} were chosen as donor and acceptor,
respectively; this pair has a critical Fo¨rster distance (ro) of 26
Å (46). Trp f luorescence-decay and energy-transfer kinetics
were used to characterize the conformational heterogeneity of
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the protein at physiological pH (7.4), in acidic (pH 4.4)
solutions, and in the presence of SDS micelles, a membrane
mimic. Distance distributions have been determined for six
DA pairs [F4WA19Y(NO2), A19Y(NO2)Y39W, F4W
Y39(NO2), V74Y(NO2)F94W, F94WY136(NO2), and F4W
Y136(NO2)]. Also, FET kinetics were measured for two DA
pairs in the vicinity of Pro-30 [F4WA19Y(NO2) and
A19Y(NO2)Y39W] to probe the effects of this disease-
related mutation on the structural and dynamical properties of
the protein.
Materials and Methods
Materials. N-acteyl-tryptophanamide (NATA), tetranitrometh-
ane, and SDS were used as received from Sigma.
Protein Preparation, Modification, and Characterization. The wild-
type human -syn expression plasmid (pRK172) was provided by
M. Goedert (Medical Council Research Laboratory of Molec-
ular Biology, Cambridge, U.K.) (47). Single Trp residues were
introduced at three different aromatic-residue positions (F4,
Y39, and F94) by site-directed mutagenesis. Because there are
four native Tyr residues (Y39, Y125, Y133, and Y136) in -syn,
all but one Tyr were mutated to phenylalanine (Phe). In two of
the mutant proteins, all native Tyr residues were mutated to Phe,
and additional Tyr residues were introduced (A19 and V74). All
site-directed mutagenesis reactions were performed by using a
QuikChange kit (Stratagene). All mutations were confirmed by
DNA sequencing at the California Institute of Technology DNA
Sequencing Core Facility. Recombinant -syn was expressed and
purified by using minor modifications of procedures described in
ref. 37. After boiling and acid-precipitation, -syn was chro-
matographed on a Q-Sepharose Fast Flow 1610 column (Am-
ersham Biosciences) equilibrated with 20 mM Tris buffer (pH
8.0) and eluted with a linear gradient from 0 to 0.5 M NaCl.
Fractions containing -syn were pooled and further purified on
a Mono-Q 1010 column (Amersham Biosciences). Protein
concentrations were determined by using a molar extinction
coefficient estimated on the basis of amino acid content: 280 
6,970 M1cm1 (48).
Nitrated proteins were generated according to procedures
described in ref. 49, with minor modifications. Purified -syn was
concentrated by ultrafiltration to 70–100 M in 20 mM Tris
buffer with 200–300 mM NaCl at pH 8.0. Tetranitromethane in
ethanol [1% (volvol), 75 l] was added dropwise to a stirred
protein solution (850 l) in the dark. After 10 min, a second
aliquot of tetranitromethane was added. After another 10 min,
the reaction was terminated by gel filtration chromatography
with a HiPrep Desalting 2610 column (Amersham Biosciences)
and finally purified on a Mono Q 1010 column. Nitrated-
protein concentrations were determined by using the published
molar extinction coefficient: 381  2,200 M1cm1 (50). The
purity of all protein samples was assessed by SDSPAGE on a
Pharmacia Phastsystem (Amersham Biosciences). The molecu-
lar weights of recombinant and chemically modified proteins
were confirmed by electrospray ionization–MS at the California
Institute of Technology ProteinPeptide Microanalytical Labo-
ratory. Absorption, CD, and luminescence spectra were mea-
sured on a Hewlett–Packard 8452 diode array spectrophotom-
eter, a 62ADS spectropolarimeter (Aviv Associates, Lakewood,
NJ), and a Fluorolog2 spectrof luorimeter (Jobin Yvon,
Longjumeau, France), respectively. All purified proteins were
concentrated by using Centriprep YM-3 (molecular weight
cutoff of 3,000; Millipore) and were stored at 80°C.
Time-Resolved Fluorescence Measurements. Trp f luorescence-
decay kinetics measurements were carried out as described in
ref. 46. Protein samples (3–5 M, unless otherwise stated) were
deoxygenated by repeated evacuationAr-fill cycles on a Schlenk
line. A polarized laser pulse (35° from vertical) from the third
harmonic (290 nm) of a regeneratively amplified femtosecond
Ti:sapphire laser (Spectra-Physics) was used as an excitation
source, and a picosecond streak camera (C5680, Hamamatsu
Photonics, Hamamatsu City, Japan) was used in the photon-
counting mode for detection. Trp emission was selected by an
interference filter (  355  5 nm). To determine the fluo-
rescence anisotropy decay {r(t) [I(t) I(t)][I(t) 2I(t)]}
(51), polarized luminescence decays [I(t) and I(t)] were col-
lected simultaneously with an optical fiber array. All protein
samples were filtered throughMicrocon YM-100 spin filter units
(molecular weight cutoff of 100,000; Millipore) to remove oli-
gomeric material before the experiments.
Data Analysis. Trp luminescence decay kinetics were modeled
with the function I(t)  Io(t)P(r)exp(ket(r)t)dr, where Io(t) is
the Trp fluorescence decay in the absence of energy transfer to
Tyr(NO2), P(r) is the probability of observing a conformation
with DA distance r, and ket(r) is the rate of energy transfer at
distance r. Two fitting protocols were used to analyze the
kinetics. In one case, a Levenberg–Marquardt least-squares
minimization algorithm (52) was used to fit to the distance
distribution of an ideal freely jointed polymer (Gaussian chain)
{P(r)dr [3(2r2	)]3/2[exp(3r22r2	)]4r2dr} (53). This sim-
plest polymer chain consists of N bonds, each of fixed length and
freely rotating. A single adjustable parameter, the mean-squared
DA distance (r2	) was extracted from these fits. Within the
Gaussian chain model, the mean DA distance is proportional to
the rms distance [r	  (8r2	3)1/2], and the effective length of
the chain segment (l
) is related to the mean squared distance
and contour (maximum) length, L, of the polymer (l
  r2	L)
(54). In the second approach, we extracted distance distributions
directly from the decay kinetics by numerical inversion of the
Laplace transform describing I(t). The critical constraint for this
inversion is the requirement that P(r) 0. A linear least-squares
(LLS) MATLAB (Mathworks, Natick, MA) algorithm with a
nonnegativity constraint (LSQNONNEG) was used to project
the narrowest P(k) distributions from the fluorescence kinetics.
A transformation using the Fo¨rster equation [r  Do(kRket)1/6,
where Do RoD1/6 and kR is the measured radiative decay rate
constant of excited NATA] recasts the P(k) distributions ob-
tained by LSQNONNEG into distributions over r (41). The
experimental limit for distances extracted from this analysis
is 40 Å.
Computational Methods. Canonical -helices and -strands were
constructed with side chains for the following DA pairs: F4W
A19Y(NO2), A19Y(NO2)Y39W, F4WY39(NO2), V74Y(NO2)
F94W, and F94WY136(NO2). Molecular-dynamics simulations
were carried out with the MPSIM program (54) to optimize the
terminal W and Y side-chain positions while holding the coordi-
nates of all other atoms fixed. In this optimization, a DREIDING
force field (55) with CHARMM22 (56) charges assigned to all
atoms was used. Center-to-center distances were obtained for an
-helix and a -strand for each DA pair.
Fig. 1. Primary amino acid sequence of human -syn. The seven imperfect
repeats are underlined. Two point mutations linked to early-onset PD (A30P
and A53T) are colored gray. Red, acidic; blue, basic; green, aromatic. Residues
in boldface have been either mutated (W, F, and Y) or chemically modified
[Y(NO2)] for FET studies.
Lee et al. PNAS  November 23, 2004  vol. 101  no. 47  16467
BI
O
PH
YS
IC
S
Results and Discussion
Trp Fluorescence and Anisotropy Decay. Trp residues incorporated
at the sites of three different aromatic amino acids (F4, Y39, and
F94) in -syn exhibit f luorescence maxima at 348 nm, indicating
that the indole side chains are largely water-exposed at pH 7.4
and 4.4 (emission maximum of NATA in water is 352 nm). In the
presence of SDS micelles (40 mM in sodium phosphate buffer at
pH 7.4), Trp fluorescence exhibits a pronounced blue shift: W4,
328 nm; W39 and W94, 338 nm (the fluorescence maximum of
NATA is 347 nm under comparable conditions). The observa-
tion that the N terminus binds to the micelle is in good
agreement with NMR studies (33–35).
The Trp fluorescence decay in the protein is not well modeled
by a single exponential function. This behavior is typical of
Trp-containing peptides and proteins; it has been attributed to
multiple, slowly interconverting (10 ns) side-chain conforma-
tions. Under all solution conditions examined (pH 7.4 sodium
phosphate buffer, pH 4.4 sodium acetate buffer, and in the
presence of SDS micelles at pH 7.4), there are at least three
distinct conformations for all three Trp residues: 1  4 ns
(35–50%), 2  1.6 ns (35–50%), and 3  0.5 ns (10%). We
have used time-resolved fluorescence polarization measure-
ments to characterize Trp mobility in the entire protein (57):
90% of Trp fluorescence depolarizes within 150 ps, and the
residual anisotropy (ro  0.06) decays with a 1-ns time constant
in pH 7.4 solution [for L-Trp in water, the anisotropy in the
absence of rotational diffusion is 0.4 (58)]. In the presence of
SDS micelles, the residual anisotropy for all Trp sites increases
(0.09), and its decay slows to 3–5 ns, revealing an increase in the
microenvironment viscosity and rigidity of the polypeptide struc-
ture. In comparison to other lipid-binding proteins, the micelle-
induced changes in -syn Trp anisotropy decay are rather
modest. Melittin binding to liposomes, for example, produces a
larger ro value (0.185) and longer rotational correlation time (10
ns) (59); Trp rotation in human apolipoprotein C-I slows dra-
matically (44 ns) in the presence of micelles (60). Although the
blue shift of the Trp fluorescence indicates that the indole is in
a strongly hydrophobic micellar environment, the rapid anisot-
ropy decay reveals that the side chain retains a considerable
degree of rotational freedom.
State of Aggregation. To probe the equilibrium state of aggrega-
tion in solution, Trp fluorescence decay kinetics were examined
at different -syn concentrations. For W39 and W94, the ob-
served kinetics were independent of protein concentration (1–30
M). However, W4 fluorescence decay kinetics exhibited a
modest dependence on [-syn], suggesting some type of inter-
protein interaction. At elevated concentrations, the fast-decay
(0.3 ns) component disappears, producing an increase in the
intermediate-decay (1 ns) population, as well as a slight increase
(10%) in the amplitude of the slow-phase rate constant. Inter-
protein FET kinetics measurements with mixtures of fluorescent
donor-only and energy acceptor-only proteins [F4WY125F
Y133FY136F and Y39(NO2)Y125FY133FY136F; Y39W
Y125FY133FY136F and Y39(NO2)Y125FY133FY136F],
however, provided no evidence for short interprotein contacts in
the 3–15 M concentration range. We conclude that the state of
protein aggregation within the low-micromolar concentration
range is constant and that, most likely, only monomeric species
are present. Moreover, Trp fluorescence decay provides no
evidence to suggest that the A30P mutation induces a change in
the aggregation state of the protein at concentrations 30 M.
To explore the effects of Tyr nitration, we examined the
dependence of intraprotein FET kinetics on protein concentra-
tion by using the A19Y(NO2)Y39W pair (300 nM to 30 M).
The kinetics varied only slightly as protein concentration in-
creased: three distinct rates were needed to fit the data, and the
amplitude for the intermediate population increased 15%.
Conformational Mapping.As a first approximation, we fit the -syn
FET kinetics to DA distance distributions for freely jointed
polymer chains (Fig. 2 and Table 1) (53). The nonrandom
residuals and large reduced 	2 values indicate that this model,
with a single adjustable parameter, does not capture all of the
features of W–Y(NO2) energy transfer in the protein. Never-
theless, the results provide an approximate description of the
conformational heterogeneity in terms of a well defined polymer
model (Gaussian chain) (53). As expected, the mean DA dis-
tances scale with the number of residues separating D and A
(Table 1). The W4–Y136 pair exhibits very little quenching, so
that the distances extracted from these fits will have larger errors.
The mean squared distance between two points in a Gaussian
chain varies as Ll
, where L is the contour (maximum) length of
the polymer and l
 is the effective length of the chain segment
(53). For a freely jointed polypeptide, the length of the chain
segment is generally taken to be 3.8 Å (the length of a residue).
Stiffer polypeptide chains will have larger values of l
. At pH 7.4,
five of the DA pairs (except W4–Y136) have chain segments in
the 13- to 16-Å range, corresponding in each case to three to four
amino acid residues. Under acidic conditions (pH 4.4), in which
-syn aggregation is accelerated (32), the chain segments in the
N-terminal region of the protein lengthen slightly. The C-
terminal DA pair (W94–Y136) exhibits a dramatic decrease in
chain-segment length (about two amino acid residues) at pH 4.4.
Apparently, the neutralization of the negative charges in the C
terminus produces a relatively flexible polymer that behaves like
a Gaussian coil. Upon addition of SDS {[SDS]  40 mM; 650
Mmicelles (61)} above the critical micelle concentration of4
mM (62), CD spectra indicate that our mutant -syns adopt
65% helical secondary structure (CD  222 nm). The Gauss-
ian fits to the FET data, however, do not reveal a consistent trend
in segment lengths in SDS. The greatest effect appears as a
substantial increase in segment length (about five residues) in the
C-terminal region of the protein.
Fits to the FET data reveal that the Gaussian chain-distance
distribution is a rough approximation of the conformational
Fig. 2. Trp-to-Y(NO2) distance distributions for freely jointed polymer chain
models of -syns under a variety of solution conditions. Green, 40 mM SDS in
20 mM NaPi buffer, pH 7.4; blue, 20 mM NaPi buffer, pH 7.4; red, 20 mM NaOAc
buffer, pH 4.4.
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heterogeneity of -syn. Consequently, we elected to extract DA
distances directly from the Trp fluorescence decay kinetics by
using a LLS procedure without recourse to a specific polymer
model. This fitting procedure produces the narrowest distance
distributions required to fit the data (using 	2 as a quality-of-fit
criterion). In all cases, the LLS method gave better fits to the
data than did the Gaussian chain model, but the general trends
in the fitting results were comparable (Fig. 3 and Table 1). For
comparison with the Gaussian chain results, we calculated mean
DA distances from the LLS fits for the pairs that do not contain
Fig. 3. Distributions of Trp-to-Y(NO2) distances in-syns extracted from FET kinetics. Results are shown for W4–Y(NO2)19 (A), Y(NO2)19–W39 (B), W4–Y(NO2)39
(C), Y(NO2)74–W94 (D), W94–Y(NO2)136 (E), and W4–Y(NO2)136 (F) under a variety of solution conditions. Green, 40 mM SDS in 20 mM NaPi buffer, pH 7.4; blue,
20 mM NaPi buffer, pH 7.4; red, 20 mM NaOAc buffer, pH 4.4. Center-to-center distances calculated for an ideal helix are shown as black lines in A–D.
Table 1. TrpY(NO2) sites and extracted mean DA distances for -syn
Solution r	LLS,* Å 	r2† r	gc,‡ Å l
,§ Å 	r2†
W4–Y(NO2)19 (n  15) pH 7.4¶ 25 1.2 23 13 43
SDS 26 1.2 26 14 48
pH 4.4** — 1.3 26 14 32
Y(NO2)19–W39 (n  20) pH 7.4 30 1.1 29 13 7.6
SDS — 1.4 26 10 12
pH 4.4 — 1.1 31 15 9.7
W4–Y(NO2)39 (n  35) pH 7.4 34 1.4 43 16 1.4
SDS 34 1.2 43 17 2.9
pH 4.4 — 1.3 45 18 1.4
Y(NO2)74–W94 (n  20) pH 7.4 — 1.2 31 15 28
SDS — 1.4 26 11 39
pH 4.4 — 1.3 31 15 40
W94–Y(NO2)136 (n  42) pH 7.4 33 1.2 43 14 1.7
SDS — 1.1 52 20 5.4
pH 4.4 28 1.1 34 8.5 1.3
W4–Y(NO2)136 (n  132) pH 7.4 — 1.6 62 8.9 3.8
SDS — 2.1 72 12 4.5
pH 4.4 — 1.5 47 5.2 1.3
n, number of chain elements (residues); —, no entry.
*Mean DA distance obtained from LLS fits.
†Reduced 	2.
‡Mean DA distance obtained from fits to a Gaussian chain model.
§Effective length for a chain element.
¶20mM NaPi buffer.
40 mM SDS in 20 mM NaPi buffer, pH 7.4.
**20 mM NaOAc buffer, pH 4.4.
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populations with r  40 Å (Table 1). The distance distributions
projected from Trp decay kinetics in pH 7.4 solutions reveal both
compact and highly extended conformations. For proteins with
the DA pair separated by 15 and 20 residues, regardless of
location in the sequence, the protein ensemble includes short (15
Å;
10%), intermediate (20 Å;45%), and extended (30 Å;
45%) polypeptides (Fig. 3 A, B, and D). The short and
intermediate populations are consistent with -helical structures
(average center-to-center distance calculated for an ideal helix:
W4–Y19, 20 Å; Y19–W39, 28 Å; and Y74–W94, 28 Å; see
Computational Methods). By contrast, if the polypeptide chains
were entirely extended (as in a -strand), we would expect
distances 60 Å (W4–Y19, 59 Å; Y19–W39, 65 Å; and Y74–
W94, 69 Å). For the Y74–W94 pair, about half of the polypeptide
ensemble exhibits distances 40 Å, consistent with highly ex-
tended conformations. As expected, increasing the number of
residues between DA pairs shifts the majority of the population
to distances beyond our experimental limit (Fig. 3 C, E, and F).
The LLS fits to the FET data collected in the presence of SDS
provide more insight into the micelle-induced conformational
changes (Fig. 3). For internal pairs, average DA distances
decrease in the presence of SDS, particularly for the Y19–W39
and W4–Y39 pairs (Fig. 3 B and C). Based on chemical shifts in
C NMR spectra, residues 18–31 are expected to have the
highest degree of -helical structure (33). However, the 19-Å
DA distance found for Y19–W39 (40% amplitude) is substan-
tially less than that of an ideal -helix (28 Å). Moreover, this pair
also exhibits a large population with distances 40 Å. Similarly,
for the Y74–W94 pair, the intermediate DA distance shortens
slightly (23–20 Å) and is well below that expected for a single
-helical segment. Interestingly, the distance distribution ob-
tained for the W4–Y19 pair remains relatively unchanged de-
spite the fact that the W4 fluorescence spectrum undergoes the
largest blue shift in SDS. As found in the Gaussian chain fits, the
distance between the W94–Y136 pair increases significantly in
SDS, presumably owing to repulsive electrostatic interactions
with the negative micelle surface. The most striking feature of
the -syn structures in the presence of SDS micelles is the lack
of tertiary contacts; there is no evidence for globular structure
despite the development of -helical secondary structure. Al-
though -syn has substantial helical content in the presence of
micelles, the FET data reveal that the protein remains highly
disordered and largely extended, in accord with previous NMR
work that indicated a lengthened helix (three turns per 11
residues) for the first 100 residues, with a break around residues
42–44 (34). Site-directed spin-labeling experiments also are
consistent with an extended helical structure for -syn in the
presence of phospholipid vesicles (37).
Acidic conditions do not change the general character of the
six DA distance distributions, but there is a slight increase in the
amplitudes of the shorter-distance populations. Our results are
consistent with small-angle x-ray scattering studies that indicate
that the average radius of gyration shrinks from 40 Å at pH 7 to
30 Å at pH 3.0 (32). Interestingly, the distances separating the
C-terminal and N- to C-terminal pairs shorten at lower pH (Fig.
3 E and F). In the W94-Y136 pair, a 12-Å population appears,
and the amplitude of the extended population decreases and
shifts to a shorter distance (30 Å). As found in the Gaussian
chain fits, the greatest structural change induced by acidic
conditions is the contraction in the C-terminal region. The
correlation with accelerated aggregation under acidic conditions
(32) raises the possibility that the high charge and extended
conformation in the C terminus serve to inhibit aggregation.
When the acidic side chains become neutralized, reduced elec-
trostatic repulsion induces shortening of the C terminus and
overall collapse of the polypeptide chain. Notably, C-terminally
truncated -syn (1–110) aggregates faster than the full-length
protein (63, 64).
Structural Effects of the A30P Mutation. The finding that single
-syn mutations (A30P and A53T) are associated with familial
early-onset PD opens the way for understanding the pathogenic
role of this protein. Consequently, FET kinetics of two
WY(NO2) pairs in the vicinity of A30P were examined as
functions of solution conditions (pH 7.4, pH 4.4, and with SDS
micelles at pH 7.4). Interestingly, the presence of this mutation
leads to an increase in the averageDA distance under all solution
conditions except acidic pH, in which some of the polypeptide
chains become shorter (Fig. 4). In pH 7.4 solutions with and
without SDS micelles, the N-terminal (W4–Y19) pair is more
extended than the internal (Y19–W39) pair. With the Pro-30
mutation, both pairs lose populations with DA distances20 Å.
The populations with intermediate DA distances (20–22 Å) shift
to slightly greater separations upon introduction of the A30P
mutation. The extended population in W4–Y19 moves from a
DA distance of 30 to40 Å. In the Y19–W39 pair, the extended
population also moves to 40 Å. The expansion of the polypep-
tide in the vicinity of the Pro-30 mutation may be attributable to
the increased stiffness of the polypeptide backbone (segment
length of about five residues) and to the helix-disrupting prop-
erty of Pro. FromC chemical shift analysis, the slight bias (10%)
for residual helical conformation in the N-terminal region is
abolished in the A30P protein in solution (65). However, in the
presence of SDS micelles, the labeled A30P derivatives exhibit
nearly identical CD spectra with helical content comparable to
the corresponding labeled pseudo-wild-type proteins. Although
there are few acidic residues in the N-terminal region (one
between W4 and Y19; three between Y19 and W39), the labeled
A30P derivatives undergo a sizeable compaction in acidic solu-
tions, possibly because of the presence of a turn in that region.
-syn and PD.The finding that singlemutations in-syn are linked
to familial early-onset forms of PD points to a central role for the
protein in the etiology of the disease. A crucial question is
whether a conformationally altered (misfolded) protein is di-
rectly involved in the pathogenic mechanism. Our FET kinetics
measurements emphasize that -syn is a highly disordered
polymer at pH 7.4 and 4.4 and in the presence of micelles. On
average, the polypeptide is more extended than expected for a
freely jointed polymer, and under some conditions the protein is
substantially less f lexible than a random coil. Nevertheless, it is
Fig. 4. Difference distance distributions of disease-related A30P -syns
extracted from FET kinetics under a variety of solution conditions. Results are
shown for W4Y(NO2)19A30P and Y(NO2)19A30PW39. Green, 40 mM SDS
in 20 mM NaPi buffer, pH 7.4; blue, 20 mM NaPi buffer, pH 7.4; red, 20 mM
NaOAc buffer, pH 4.4.
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likely that the protein is highly dynamic and that conformers
interchange on very short (approximately microsecond) time
scales. We find that modifications of solution conditions and
amino acid sequence do not produce unique conformational
changes; rather, these perturbations result in subtle redistribu-
tions of the structures comprising the protein ensemble. The
likelihood of identifying a unique -syn toxic conformer seems
rather remote.
It has been suggested that the death of dopaminergic neurons
in PD is the ultimate result of a cascade of events involving
inhibition of mitochondrial complex I, -syn aggregation, and
proteosome dysfunction (39, 40). The role of -syn in this
complex disease progression is likely to involve its interactions
with other biomolecules (e.g., vesicles, enzymes, chaperones, and
proteosomes) (39, 40). We have demonstrated that FET kinetics
measurements can provide unique insights into the conforma-
tional heterogeneity of -syn that are not apparent from other
spectroscopic measurements. The greatest power of our ap-
proach may lie in its ability to determine how different -syn
subpopulations interact with neuronal compounds and struc-
tures that are implicated in the pathogenic process.
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